Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | ADH1A | P07327 | 1/20 | 0.42 |
| ▸ | ADH4 | P08319 | 1/20 | 0.42 |
| ▸ | ADH7 | P40394 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | GBA1 | P04062 | 4/20 | 0.37 |
| ▸ | CASP2 | P42575 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27313282 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL27757402 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL11650879 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL11748589 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL7530779 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL9295907 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL6914040 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL28849523 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL16618599 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL2549072 | 1.00 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116023555-A | External electron donor, application thereof, catalyst system for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-116023548-A | External electron donor composition, application thereof, catalyst system and olefin polymerization method | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-100422429-C | Treating agent for synthetic fiber and method for treating synthetic fiber | TAKEMOTO OIL & FAT CO LTD (JP) | 2008-10-01 | — | — | CN | disclosed |
| US-20070270472-A1 | Amino, Amino Acid or Peptide Conjugates of Retinoic Acid | DSM IP ASSETS B.V. (NL) | 2007-11-22 | — | — | US | disclosed |
| CN-1769581-A | Treating agent for synthetic fiber and method for treating synthetic fiber | TAKEMOTO OIL & FAT CO LTD (JP) | 2006-05-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270472-A1 | Amino, Amino Acid or Peptide Conjugates of Retinoic Acid | RARA, RARG, RARB | EPHX1 2574/4885TSHR 651/4885ALDH1A1 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.